Júlia Laporte-Amargós

Inappropriate Empirical Antibiotic Treatment in High-risk Neutropenic Patients With Bacteremia in the Era of Multidrug Resistance

Gemma Martínez‐Nadal, Pedro Puerta‐Alcalde, Carlota Gudiol et al. · Clinical Infectious Diseases · 2019 · 164 citations

Pharmacy, Infectious Diseases, Microbiology +16

Breakthrough invasive fungal infection among patients with haematologic malignancies: A national, prospective, and multicentre study

Pedro Puerta‐Alcalde, Patricia Monzó, Manuela Aguilar‐Guisado et al. · Journal of Infection · 2023 · 67 citations · Full text

Medicine, Hematology, Infectious Diseases +17

Clinical Predictive Model of Multidrug Resistance in Neutropenic Cancer Patients with Bloodstream Infection Due to Pseudomonas aeruginosa

Carlota Gudiol, Adaia Albasanz‐Puig, Júlia Laporte-Amargós et al. · Antimicrobial Agents and Chemotherapy · 2020 · 58 citations · Full text

Life Sciences, Infectious Diseases, Antimicrobial Pharmacotherapy +16

Impact of the Inclusion of an Aminoglycoside to the Initial Empirical Antibiotic Therapy for Gram-Negative Bloodstream Infections in Hematological Neutropenic Patients: a Propensity-Matched Cohort Study (AMINOLACTAM Study)

Adaia Albasanz‐Puig, Carlota Gudiol, Pedro Puerta‐Alcalde et al. · Antimicrobial Agents and Chemotherapy · 2021 · 48 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +16

Real-Life Use of Ceftolozane/Tazobactam for the Treatment of Bloodstream Infection Due to Pseudomonas aeruginosa in Neutropenic Hematologic Patients: a Matched Control Study (ZENITH Study)

Alba Bergas, Adaia Albasanz‐Puig, Ana Fernández‐Cruz et al. · Microbiology Spectrum · 2022 · 32 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +14